Meanwhile, back in the pharma wars
The PMPRB’s recent experience, which saw the new guidelines challenged in court by the pharmaceutical industry, provides a glimpse of the challenge ahead.

OTTAWA—Never has the need for national pharmacare been more evident than during the current pandemic, as access to medications has become more iffy as a result of lost workplace health insurance during rising unemployment and widespread strains on household finances.
In one step toward the creati...
SPONSORED CONTENT
Get Weekend Point of View Newsletter
A round up of the past week’s opinion writers and columnists on Saturdays and Sundays.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy












